Edition:
United States

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

3.19USD
15 Jun 2018
Change (% chg)

$0.35 (+12.32%)
Prev Close
$2.84
Open
$2.85
Day's High
$3.23
Day's Low
$2.82
Volume
536,434
Avg. Vol
325,661
52-wk High
$8.61
52-wk Low
$1.41

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.94 -0.320
FY 2017 Dec '17 1.62 -0.507
Sep '17 1.55 -0.556
Jun '17 1.15 -0.677
Mar '17 1.02 -0.603
FY 2016 Dec '16 4.06 -0.376
Sep '16 1.72 -0.537
Jun '16 1.45 -0.473
Mar '16 1.16 -0.870
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 1.28 1.40 1.16 --
Quarter Ending Sep-18 2 1.48 1.57 1.40 --
Year Ending Dec-18 2 5.22 5.30 5.14 1.11
Year Ending Dec-19 2 5.38 5.40 5.36 0.50
Earnings (per share)
Quarter Ending Jun-18 3 -0.39 -0.32 -0.50 --
Quarter Ending Sep-18 3 -0.37 -0.26 -0.51 --
Year Ending Dec-18 3 -1.52 -1.23 -2.04 -2.41
Year Ending Dec-19 2 -1.17 -1.11 -1.24 -2.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 240.92 34.18
P/E High - Last 5 Yrs. -- 292.40 47.65
P/E Low - Last 5 Yrs. -- 101.52 25.16
Beta -- 0.73 0.78
Price to Sales (TTM) 21.87 277.70 8.57
Price to Book (MRQ) 1.83 23.83 4.35
Price to Tangible Book (MRQ) 1.91 31.28 6.03
Price to Cash Flow (TTM) -- 141.17 22.78
% Owned Institutions 67.73 10.77 2.40

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.24 -6.56
Payout Ratio(TTM) -- 42.16 39.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -7.74 24.66 5.00
Sales (TTM) vs TTM 1 Yr. Ago -36.19 138.03 12.50
Sales - 5 Yr. Growth Rate -- 30.82 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.99 -77.30 40.63
EPS (TTM) vs TTM 1 Yr. Ago -3.56 -- --
EPS - 5 Yr. Growth Rate -- 48.49 8.03
Capital Spending - 5 Yr. Growth Rate -- 36.28 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.56
Current Ratio (MRQ) 8.08 6.39 3.64
LT Debt to Equity (MRQ) 0.00 20.82 12.92
Total Debt to Equity (MRQ) 0.00 25.11 17.37
Interest Coverage (TTM) -- -142.62 35.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.39 54.96
Gross Margin - 5 Yr. Avg. -- 54.91 52.86
EBITD Margin (TTM) -1,050.38 -- --
EBITD - 5 Yr. Avg -- -171.18 15.70
Operating Margin (TTM) -1,064.18 -947.86 -0.76
Operating Margin - 5 Yr. Avg. -- -184.89 10.94
Pre-Tax Margin (TTM) -1,052.11 -831.06 1.32
Pre-Tax Margin - 5 Yr. Avg. -- -188.29 11.12
Net Profit Margin (TTM) -1,052.11 -824.15 -1.97
Net Profit Margin - 5 Yr. Avg. -- -186.71 7.48
Effective Tax Rate (TTM) -- 15.20 29.90
Effective Tax Rate - 5 Yr. Avg. -- 19.22 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) 105,240 21,950,230 736,829,609
Net Income/Employee (TTM) -1,107,240 -523,802 85,814,668
Receivable Turnover (TTM) -- 18.22 6.06
Inventory Turnover (TTM) -- 2.86 3.65
Asset Turnover (TTM) 0.07 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -70.20 -3.98 10.37
Return on Assets - 5 Yr. Avg. -- -1.14 11.09
Return on Investment (TTM) -78.23 -5.87 13.17
Return on Investment - 5 Yr. Avg. -- 1.58 14.39
Return on Equity (TTM) -87.03 -7.71 15.15
Return on Equity - 5 Yr. Avg. -- -3.84 15.73
  1 Year 3 Year 5 Year
Sales % -36.30 1.22 --
EPS (TTM) % -13.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteostasis Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.84%
# of Holders: 63
Total Shares Held: 24,475,794
3 Mo. Net Change: 552,095
# New Positions: 18
# Closed Positions: 21
# Increased Positions: 34
# Reduced Positions: 34
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.